Indeed, CD1C+ DCs have been correlated with the induction of anti-tumor T cell responses through production of activating cytokines and expression of co-stimulatory molecules that support the function of both CD4+ and CD8+ T cells [86,87]. The gene discussed is CD8A; the disease is neoplasm.